TrialFrontiers in immunology2021

Ivacaftor Reduces Inflammatory Mediators in Upper Airway Lining Fluid From Cystic Fibrosis Patients With a G551D Mutation: Serial Non-Invasive Home-Based Collection of Upper Airway Lining Fluid.

Jochen G Mainz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.